CSIMarket
 


Amgen Inc   (AMGN)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 

AMGN's Income from Cont. Operations Growth by Quarter and Year

Amgen Inc 's Income from Cont. Operations results by quarter and year




AMGN Income from Cont. Operations (in millions $) FY 2021 FY 2020 FY 2019 FY 2018
IV Quarter December - 1,615.00 1,703.00 1,928.00
III Quarter September - 2,021.00 1,968.00 1,859.00
II Quarter June - 1,803.00 2,179.00 2,296.00
I Quarter March 1,646.00 1,825.00 1,992.00 2,311.00
FY   1,646.00 7,264.00 7,842.00 8,394.00



AMGN Income from Cont. Operations first quarter 2021 Y/Y Growth Comment
Amgen Inc reported decrease in Income from Cont. Operations in the first quarter by -9.81% to $ 1,646.00 millions, from the same quarter in 2020.
The decrease in the first quarter Amgen Inc 's Income from Cont. Operations compares unfavorably to the Company's average Income from Cont. Operations doubling of 129.86%.

Looking into first quarter results within Biotechnology & Drugs industry 5 other companies have achieved higher Income from Cont. Operations growth. While Amgen Inc ' s Income from Cont. Operations decline of -9.81% ranks overall at the positon no. 580 in the first quarter.




AMGN Income from Cont. Operations ( Y/Y Growth %) 2021
2020 2019 2018
IV Quarter December - -5.17 % -11.67 % -
III Quarter September - 2.69 % 5.86 % -8.02 %
II Quarter June - -17.26 % -5.1 % 6.74 %
I Quarter March -9.81 % -8.38 % -13.8 % 11.59 %
FY   - -7.37 % -6.58 % 324.15 %

Financial Statements
Amgen Inc 's first quarter 2021 Income from Cont. Operations $ 1,646.00 millions AMGN's Income Statement
Amgen Inc 's first quarter 2020 Income from Cont. Operations $ 1,825.00 millions Quarterly AMGN's Income Statement
New: More AMGN's historic Income from Cont. Operations Growth >>


AMGN Income from Cont. Operations (Quarter on Quarter Growth %)

2021
2020 2019 2018
IV Quarter December - -20.09 % -13.47 % 3.71 %
III Quarter September - 12.09 % -9.68 % -19.03 %
II Quarter June - -1.21 % 9.39 % -0.65 %
I Quarter March 1.92 % 7.16 % 3.32 % -
FY (Year on Year)   - -7.37 % -6.58 % 324.15 %




Income from Cont. Operations first quarter 2021 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #6
Healthcare Sector #46
Overall #580

Income from Cont. Operations Y/Y Growth Statistics
High Average Low
7178.57 % 129.86 % -98.64 %
(June 30. 2007)   (June 30. 2006)
Income from Cont. Operations first quarter 2021 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #6
Healthcare Sector #46
Overall #580
Income from Cont. Operations Y/Y Growth Statistics
High Average Low
7178.57 % 129.86 % -98.64 %
(June 30. 2007)   (June 30. 2006)

Income from Cont. Operations by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Amgen Inc 's Q/Q Income from Cont. Operations Growth


Income from Cont. Operations Q/Q Growth Statistics
High Average Low
7771.43 % 124.15 % -98.6 %
(Sep. 30, 2006)  


AMGN's I. Quarter Q/Q Income from Cont. Operations Comment
Amgen Inc achieved in the I. Quarter 2021 below company average Income from Cont. Operations growth of 1.92% quarter on quarter, to $ 1,646.00 millions.

Within Biotechnology & Drugs industry 3 other companies have achieved higher Income from Cont. Operations quarter on quarter growth. While Amgen Inc 's Income from Cont. Operations growth quarter on quarter, overall rank is 402.


Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #4
Healthcare Sector #27
Overall #402
Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #4
Healthcare Sector #27
Overall #402
Income from Cont. Operations Q/Q Growth Statistics
High Average Low
7771.43 % 124.15 % -98.6 %
(Sep. 30, 2006)  


AMGN's I. Quarter Q/Q Income from Cont. Operations Comment
Amgen Inc achieved in the I. Quarter 2021 below company average Income from Cont. Operations growth of 1.92% quarter on quarter, to $ 1,646.00 millions.

Within Biotechnology & Drugs industry 3 other companies have achieved higher Income from Cont. Operations quarter on quarter growth. While Amgen Inc 's Income from Cont. Operations growth quarter on quarter, overall rank is 402.


Amgen Inc 's 12 Months Income from Cont. Operations Growth Year on Year


Income from Cont. Operations TTM Growth

12 Months Ending
(Mar 31 2021)
12 Months Ending
(Dec 31 2020)
12 Months Ending
(Sep 30 2020)
12 Months Ending
(Jun 30 2020)
12 Months Ending
(Mar 31 2020)
Cumulative Income from Cont. Operations 12 Months Ending $ 7,085.00 $ 7,264.00 $ 7,352.00 $ 7,299.00 $ 7,675.00
Y / Y Income from Cont. Operations Growth (TTM) -7.69 % -7.37 % -8.86 % -8.28 % -4.95 %
Year on Year Income from Cont. Operations Growth Overall Ranking # 537 # 1150 # 1048 # 1040 # 1115
Seqeuential Income from Cont. Operations Change (TTM) -2.46 % -1.2 % 0.73 % -4.9 % -2.13 %
Seq. Income from Cont. Operations Growth (TTM) Overall Ranking # 675 # 1360 # 1178 # 1186 # 1079




Cumulative Income from Cont. Operations growth Comment
Amgen Inc 's cumulative 12 months Income from Cont. Operations continue to decline, but on the faster rate at -7.69% year on year, at Mar 31 2021 compare to the -7.37% decrease at Dec 31 2020. If the Amgen Inc 's fiscal year would end at Mar 31 2021, annual Income from Cont. Operations would be $7,085 millions.

In the Healthcare sector 38 other companies have achieved higher trailing twelve month Income from Cont. Operations growth. While Total ranking has impoved so far to 537, from total ranking in previous quarter at 1150.

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
281.2 %
4.75 %
-75.8 %
(Dec 31 2018)  

Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry # 4
Healthcare Sector # 39
Overall # 536

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
324.15 %
21.1 %
-74.37 %
(Dec 31 2018)  


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry # 8
Sector # 51
S&P 500 # 675
Cumulative Income from Cont. Operations growth Comment
Amgen Inc 's cumulative 12 months Income from Cont. Operations continue to decline, but on the faster rate at -7.69% year on year, at Mar 31 2021 compare to the -7.37% decrease at Dec 31 2020. If the Amgen Inc 's fiscal year would end at Mar 31 2021, annual Income from Cont. Operations would be $7,085 millions.

In the Healthcare sector 38 other companies have achieved higher trailing twelve month Income from Cont. Operations growth. While Total ranking has impoved so far to 537, from total ranking in previous quarter at 1150.

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
281.2 %
4.75 %
-75.8 %
(Dec 31 2018)  


Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry # 4
Healthcare Sector # 39
Overall # 536

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
324.15 %
21.1 %
-74.37 %
(Dec 31 2018)  


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry # 8
Sector # 51
S&P 500 # 675




Other Income from Cont. Operations Growth
Biotechnology & Drugs Industry Income from Cont. Operations Growth Trends and Statistics
Healthcare Sector Income from Cont. Operations Growth Statistics
Income from Cont. Operations Growth Trends for overall market
AMGN's Income from Cont. Operations Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Income from Cont. Operations Growth
Lowest Ranking Income from Cont. Operations Growth
Income from Cont. Operations Growth for AMGN's Competitors
Income from Cont. Operations Growth for Amgen Inc 's Suppliers
Income from Cont. Operations Growth for AMGN's Customers

You may also want to know
AMGN's Annual Growth Rates AMGN's Profitability Ratios AMGN's Asset Turnover Ratio AMGN's Dividend Growth
AMGN's Roe AMGN's Valuation Ratios AMGN's Financial Strength Ratios AMGN's Dividend Payout Ratio
AMGN's Roa AMGN's Inventory Turnover Ratio AMGN's Growth Rates AMGN's Dividend Comparisons



Companies with similar Income from Cont. Operations decline for the quarter ending Mar 31 2021 within Healthcare SectorY/Y Change %Income from Cont. Operations for the quarter ending Mar 31 2021
Eli Lilly And Company-6.95%$ -6.948 millions
Amgen Inc -9.81%$ -9.808 millions
Baxter International Inc -9.91%$ -9.910 millions
Alexion Pharmaceuticals Inc -12.27%$ -12.267 millions
Pacira Biosciences inc -12.62%$ -12.623 millions
Msa Safety Inc-16.44%$ -16.442 millions
Acadia Healthcare Company Inc -32.13%$ -32.134 millions
Teleflex Incorporated-42.92%$ -42.916 millions
Viemed Healthcare Inc -60.31%$ -60.311 millions
Biogen Inc -70.95%$ -70.946 millions
Biomarin Pharmaceutical Inc-78.65%$ -78.655 millions
United Therapeutics Corporation-79.45%$ -79.448 millions
Align Technology inc -86.80%$ -86.801 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

CODI's Profile

Stock Price

CODI's Financials

Business Description

Fundamentals

Charts & Quotes

CODI's News

Suppliers

CODI's Competitors

Customers & Markets

Economic Indicators

CODI's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071